NCT07281391

IOP Reduction in Pigmentary Glaucoma Using DSLT

Direct Selective Laser Trabeculoplasty Providing Effective Intraocular Pressure Reduction in Pigmentary Glaucoma Patients

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 45 (estimated)
• Sponsor: Mann Eye Institute · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.

Conditions

• Pigmentary Dispersion Syndrome
• Pigmentary Dispersion Glaucoma

Interventions

Type	Name	Description
DEVICE	Voyager DSLT	DSLT is an innovative adaptation of traditional SLT. Rather than using a gonioscopic lens, DSLT applies laser energy directly through the limbus to the trabecular meshwork in a few seconds.

Timeline

• Start date: 2026-03-19
• Primary completion: 2027-04-01
• Completion: 2027-04-01
• First posted: 2025-12-15
• Last updated: 2026-04-09

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study